Canada Numinus launches ketamine-assisted therapy in Toronto Neurology Centre of Toronto in Forest Hill expands its therapy catalogue Rowan DunneSeptember 21, 2022
Medical and Pharmaceutical Eastman realizes its recycling and plastics circular economy ambitions Eastman's aim is circularity, and collaborations like help change the industry, using molecular recycling to promote a circular healthcare economy. Joseph MortonSeptember 20, 2022
Medical and Pharmaceutical IceCure Medical aims to bring cold cancer treatment to Vietnam Liver, lung and breast cancer were the three most prevalent cancers in Vietnam in 2020, according to the World Health Organization. Joseph MortonAugust 31, 2022
Canada PharmAla Biotech applies for patent on 6 novel MDMA-like molecules Application follows successful pre-clinical animal studies at the University of Arkansas Rowan DunneAugust 29, 2022
Cannabis Tilray receives approval for CBD oral solution in Australia and New Zealand Flagship product from company's medical cannabis division now set for clinical trial use Rowan DunneAugust 23, 2022
Canada Canntab Therapeutics enters the Nova Scotia cannabis marketplace Cannabinoid tablet supplier expands its Canadian distribution network Rowan DunneAugust 22, 2022
AI and Autonomy The Mugglehead technology roundup: sleep technologies Here's a bird's eye view of the sleep technology industry. Joseph MortonAugust 17, 2022
Medical and Pharmaceutical Natera and RenaCARE aim for early detection of kidney disease Natera (NASDAQ:NTRA) acquired full enrolment for the RenaCARE (Renasight Clinical Application, Review and Evaluation) study, which is a prospective, multi-center clinical trial to determine... Joseph MortonAugust 11, 2022
Medical and Pharmaceutical Context Therapeutics and Menarini Group put together clinical trial for breast cancer drug Breast cancer is the second most common cancer among women. Joseph MortonAugust 2, 2022
Business Entourage Health partners with HelloMD to expand resources to patients Starseed Medicinal services' patient base grew over 50 per cent since 2019 Natalia Buendia CalvilloJuly 26, 2022